Advanced Filters
noise
Found 64,777 clinical trials

ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area

The purpose of the study is to find out if Latino families living in rural parts of Florida are interested in learning about cancer prevention through our ProSalud program and whether it helps them make healthier choices to lower their risk of cancer. The study will also gather people's opinions …

18 years of age All Phase N/A
C Clinical Research Coordinator

Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)

This trial is a randomized study to evaluate the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.

22 years of age All Phase 3
M Mireille Jacobson, PhD

In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy

Women, older adults, individuals from communities of color, particularly Black and Latino persons, and individuals with lower socioeconomic status are historically underrepresented in clinical research. This is true across a range of clinical areas but no more so than in Alzheimer's Disease Research. The purpose of this study is to …

50 years of age All Phase N/A
L Lindsay Baker, PhD

Effects of a Glycerol-Electrolyte Beverage on Fluid Balance in Healthy Euhydrated Men and Women

Glycerol and sodium are osmotically-active ingredients that promote fluid retention via renal water reabsorption. The purpose of this study is to compare the effects of a glycerol-electrolyte beverage on fluid balance in healthy euhydrated men and women

18 - 50 years of age All Phase N/A
P Pamela Ganschow, MD

Implementation of Population Breast Cancer Genetic Services in Federally Qualified Health Centers (FQHC)

The goal of this clinical trial is for researchers to compare the effectiveness of a mainstreamed model of genetic testing (MGT) with an enhanced standard of care model (SOC+) on the uptake of genetic testing among at-risk patients in an urban Federally Qualified Health Center (primary care) setting using a …

25 years of age All Phase N/A
M Mohana Priya Santhan Ramesh Kumar Padma, Masters

Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation

Evaluate the feasibility, safety, and preliminary efficacy of deep Transcranial Magnetic Stimulation (dTMS) as an adjunctive treatment for adolescents hospitalized with major depressive disorder (MDD).

14 - 18 years of age All Phase N/A
S Sara Burns, MSCR

Duke Cardiometabolic Prevention Clinic's Impact on High-risk Cardiovascular Patients With Uncontrolled Risk Factors

This project is studying whether a team-based specialty clinic can help people with type 2 diabetes and heart disease better manage their blood pressure and cholesterol. The clinic includes coordinated care from heart doctors, kidney doctors, diabetes specialists, and liver doctors. The study will compare two groups of patients: one …

18 years of age All Phase N/A
D Dike Ojji, MBBS, PhD

Diabetes Management for Primary Healthcare Centers.

The purpose of this study, "Integrating diabetes care into Primary Healthcare Centers (PHCs) in Abuja, Nigeria: a pilot study," is to screen, diagnose, treat, and educate diabetes patients in two selected PHCs in Abuja. This single-arm pilot trial will test the feasibility of integrated diabetes care, measure the implementation outcomes, …

18 - 99 years of age All Phase N/A
D Danielle Boos

A Study Of Resilience And Mental Well-Being Through Breathing Practice For Clinical Care Professionals

The purpose of this study is to assess the immediate and long-term effects of structured breathing on clinical symptoms related to mental health including anxiety, depression, perceived stress, and sleep quality.

18 - 85 years of age All Phase N/A
A Amir T Fathi, MD

Ivosidenib as Post-HSCT Maintenance for AML

This is a Phase 2 study of the study drug, ivosidenib (a mutant IDH1 inhibitor), compared to placebo, given to patients with IDH1-mutant acute myeloid leukemia (AML) after hematopoietic stem cell transplantation (HCT).

18 - 75 years of age All Phase 2

Simplify language using AI